![BITF](https://dbtnews.com/wp-content/uploads/2020/01/Image-64.png)
Elevation Oncology Inc [ELEV] is 402.79% higher this YTD. Is it still time to buy?
Elevation Oncology Inc [NASDAQ: ELEV] jumped around 0.06 points on Thursday, while shares priced at $2.70 at the close of the session, up 2.27%. Compared to the average trading volume of 761.76K shares, ELEV reached a trading volume of 3896362 in the most recent trading